Although transcatheter aortic valve implantation (TAVI) has revolutionised the landscape of treatment for aortic stenosis. there exists a cohort of patients where TAVI is deemed futile. Among the pivotal high-risk trials. one-third to half of patients either died or received no symptomatic benefit from the procedure at 1 year. https://emporiumsmokeshopstles.shop/product-category/cases/